BioSpace News Archive

In the United States, approximately 1.3 million women are expected to reach menopause every year.

Maria Sophocles, MD, OBGYN offers advice to maintain vaginal health, avoid issues down there, and stay safe when sexually active

IFF (NYSE: IFF) (Euronext Paris: IFF) (TASE: IFF), a leading innovator of taste, scent, nutrition and ingredients today opens the doors to its Home & Fabric Care Innovation Center at Bell Works in Holmdel, New Jersey.

Atlas Antibodies AB announced the introduction of pre-quantified QPrEST™ Protein Standards for absolute quantification of proteins in biological samples such as cell lysate and plasma using liquid chromatography–mass spectrometry.

AdAlta Limited announced it has signed a commercial agreement for its i-body platform with global medical technology firm, GE Healthcare.

NovaBay® Pharmaceuticals, Inc. announces that Yenyou (Jeff) Zheng, Ph.D. has joined the Company’s board as an independent director.

The Next Generation Of This Pioneering Meniscal Repair Technology

Seattle Genetics, Inc. (Nasdaq:SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced that the U.S. Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for the investigational agent enfortumab vedotin

The Hyundai Hope On Wheels non-profit embarks on a nationwide tour this September during Childhood Cancer Awareness Month to award new grants for pediatric cancer, surpassing $160 million in lifetime funding for research

Amplyx Pharmaceuticals, a biotech company dedicated to developing innovative therapies for debilitating and life-threatening diseases in patients with compromised immune systems, announced today that it has executed an exclusive worldwide license agreement with Novartis under which Amplyx has acquired the rights to the Phase 2 anti-BK virus (BKV) monoclonal antibody, MAU868, for the treatment and prevention of BKV disease